The expression of these immunosuppressive factors by cancer cells can be blocked by monoclonal antibodies against proteins such as PD-1, PD-L1, and CTAL-4, which prompt normal recognition by immune cells to kill cancer cells [146]. Here, PDCD1 is linked to cancer.